# Safety Study of Nicotinamide to Treat Alzheimer's Disease

> **NCT00580931** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of California, Irvine** · enrollment: 50 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** Nicotinamide
- **DRUG:** Enduramide placebo

## Key facts

- **NCT ID:** NCT00580931
- **Lead sponsor:** University of California, Irvine
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2017-01-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00580931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00580931, "Safety Study of Nicotinamide to Treat Alzheimer's Disease". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT00580931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*